Skip to main content
Market Insights Health
- United States
- Revenue in the Cannabis market in the United States is forecasted to reach US$42.98bn in 2024.
- The revenue is anticipated to demonstrate an annual growth rate (CAGR 2024-2029) of 2.89%, leading to a market volume of US$49.56bn by 2029.
- When compared globally, the United States is expected to generate the highest revenue in 2024, amounting to US$42.98bn.
- In terms of per person revenues in 2024, US$279.90 are generated based on total population figures.
- The United States sees a growing trend in cannabis investments, with increased focus on regulatory developments and market expansion.
Key regions: United States, Canada, Netherlands, Germany, Thailand
Definition:
The Cannabis market covers products derived from the cannabis plant used for medical or recreational purposes. These products may include dried flowers, oils, edibles, tinctures, and topicals. Depending on the regulations in each country or state, these products are provided by dispensaries, pharmacies, and/or online platforms. They may be consumed in the form of smoking, vaporizing, eating, or applying topically.
Structure:
The market includes Medical, Pharmaceutical, and Recreational Cannabis as well as CBD Products. The Medical and Pharmaceutical Cannabis markets include products used to treat conditions such as chronic pain, mental disorders, and other medical conditions. The Recreational Cannabis and the the CBD Products markets include products used for personal enjoyment or leisure purposes. All cannabis markets include various forms of cannabis such as flowers, concentrates, edibles, and topicals.
Additional information:
Market values represent the revenues generated by retail prices paid to vendors, either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), companies (B2B), and governments (B2G).
Company examples: Canopy Growth Corporation, Aurora Cannabis, Curaleaf Holdings, Tilray, Green Thumb Industries, Trulieve Cannabis, Verano Holdings.
in-scope
- Recreational Cannabis
- Medical Cannabis
- Pharmaceutical Cannabis
- CBD Products
out-of-scope
- Illegal cannabis
- Cannabis cultivated for private use
Cannabis
- Recreational Cannabis
- Medical Cannabis
- CBD Products
- Pharmaceutical Cannabis
Related markets:
Medical Technology
OTC Pharmaceuticals
Digital Health
Pharmaceuticals
Hospitals
Mental Health
Pharmacies
Please wait
Download PDF FAQs and more info on the methodology
Market
Region
Region comparison
Currency
Analyst Opinion
The Cannabis market in United States has been experiencing significant growth and evolution in recent years. Customer preferences: Trends in the market: Local special circ*mstances: Underlying macroeconomic factors:
Methodology
Data coverage:
Data encompasses B2B and B2C enterprises. Figures are based on companies' revenues, funding values and global consumer survey data. Revenues include retail, sales and taxes.
Modeling approach / Market size:
Market sizes are determined by a Top-Down approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports, third-party data. Next, we use relevant key market indicators and data from country-specific associations such as tobacco spending per capita, medical product spending per capita, consumer spending and consumer spending for recreation purposes, population. This data helps us to estimate the market size for each country individually.
Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function.
Additional Notes:
The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.
Overview
- Revenue
- Users
- Analyst Opinion
- Global Comparison
- Methodology
- Key Market Indicators
Please wait
Contact
Get in touch with us. We are happy to help.
Meredith Alda
Sales Manager– Contact (United States)
Tel
+1 914 619-5895
Mon - Fri, 9am - 6pm (EST)
Yolanda Mega
Operations Manager– Contact (Asia)
Tel
+65 6995 6959
Mon - Fri, 9am - 5pm (SGT)
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)
Mon - Fri, 10:00am - 6:00pm (JST)
Lodovica Biagi
Director of Operations– Contact (Europe)
Tel
+44 (0)20 8189 7000
Mon - Fri, 9:30am - 5pm (GMT)
Carolina Dulin
Group Director - LATAM– Contact (Latin America)
Tel
+1 212 419-5774
Mon - Fri, 9am - 6pm (EST)
Unlock Market Insights with a Professional Account
- Get immediate access to all Market Insights, reports & statistics
- Download data in multiple formats for collaborative research
- Includes usage & publication rights for sharing data externally
Buy Professional Account
Already have an account? Login
